Donate

Forum

Fri, Jul 12, 2013 -- 9:00 AM

Genetic Mutation Holds Promise for Cholesterol-Busting Drug


Download audio (MP3)

Getty Images
Getty Images

After two women with similar genetic mutations were found to have astoundingly low cholesterol, drug companies began racing to release a super-drug that mimics that cholesterol-destroying mutation. New York Times science writer Gina Kolata and the director of the National Heart, Lung, and Blood Institute, Dr. Gary Gibbons, discuss these findings, and whether a super-drug could make high cholesterol a thing of the past.

Host: Dave Iverson

Guests:

  • Dr. Gary Gibbons, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health
  • Gina Kolata, science reporter for the New York Times

Become a KQED sponsor

Audio Archive

Episodes by Date

Calendar is loading...
Loading...

Be a Part of Forum

Do You Live in the Bay Area on Less Than $33,000?

Forum wants to hear your story as part of our Priced Out series

Follow us on Twitter

Twitter bird in blue

Stay updated on show topics, relevant articles, and easily submit your questions.